Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

voest-emile

Emile Voest

Netherlands Cancer Institute

Netherlands

Emile Voest is Professor of Medical Oncology and serves as Medical Director on the Executive Board of the Netherlands Cancer Institute in Amsterdam. He also founded and serves on the Board of the Center for Personalized Cancer Treatment (a national personalized medicine program involving >45 hospitals) and member of the Supervisory Board of the Hartwig Medical Foundation (national sequencing center in the Netherlands). He was previously a member of the ESMO Council (as Chair of the Publishing Committee).

In addition to his clinical and managerial responsibilities he is senior group leader at the Netherlands Cancer Institute and the Oncode Institute. His laboratory group is devoted to bringing personalized medicine to patients and is focused on the identification of biomarkers that predict efficacy of immunotherapy and chemotherapy. The results from these studies are subsequently translated in clinical studies. These translational approaches are performed across tumor types with emphasis on epithelial tumors.

He has authored >280 peer reviewed scientific papers.

Last update: October 2022

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.